Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 633)
Posted On: 03/28/2021 3:46:35 AM
Post# of 154604
Posted By: ohm20
Re: TechGuru #84437
Quote:
My humble conclusion: No single drug will treat LH.



Might want a vaccine to boost antibodies but other than that leronlimab has the best chance at being a single drug solution.

Recently someone asked Dr. Patterson about leronlimab's 100% occupancy vs. maraviroc's 50%. His response -

Quote:
Blocks on what cell? Maybe one doesn’t want complete blockade. In my November Webinar I talked about tailoring dosing to inhibit Tregs but not inhibit effector CD8 T-cells. Remember both good and bad cells express CCR5. That is how IncellDx does RO on a cell type specific manner



He seems to forget that he is the one that showed recovery of CD8+ T-cell counts with leronlimab. There was a study with maraviroc that showed very little improvement in NKT cell levels, that shouldn't be the case with leronlimab. Maybe he's feeling threatened that leronlimab may be a one drug solution for longhaulers.














(15)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site